Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
1.180
-0.070 (-5.60%)
At close: Dec 5, 2025, 4:00 PM EST
1.240
+0.060 (5.08%)
After-hours: Dec 5, 2025, 6:55 PM EST
Citius Pharmaceuticals Employees
Citius Pharmaceuticals had 23 employees as of September 30, 2024. The number of employees increased by 1 or 4.55% compared to the previous year.
Employees
23
Change (1Y)
1
Growth (1Y)
4.55%
Revenue / Employee
n/a
Profits / Employee
-$1,782,197
Market Cap
21.80M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CTXR News
- 1 day ago - Citius Oncology Expands LYMPHIR™ Distribution to Turkey and Middle East Countries Through Exclusive Agreement with Er-Kim - PRNewsWire
- 4 days ago - Citius Oncology Announces U.S. Commercial Launch of LYMPHIR™, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL) - PRNewsWire
- 10 days ago - Citius Oncology to Exhibit at the 67th American Society of Hematology (ASH) Annual Meeting - PRNewsWire
- 14 days ago - Citius Oncology to Advance Commercial Launch of LYMPHIR™ with Verix AI Integration - PRNewsWire
- 6 weeks ago - Citius Pharmaceuticals Announces the Closing of Registered Direct Offering of $6.0 Million Priced At-The-Market Under Nasdaq Rules - PRNewsWire
- 6 weeks ago - PACCAR Posts Downbeat Earnings, Joins Neuphoria Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
- 6 weeks ago - Citius Pharmaceuticals Announces a Registered Direct Offering of $6.0 Million Priced At-The-Market Under Nasdaq Rules - PRNewsWire
- 7 weeks ago - Citius Pharmaceuticals and Citius Oncology to Participate in Upcoming October 2025 Conferences - PRNewsWire